Showing results (1-10 of 549) with videos related to
Sort By:
Pageof 55
Annual Review of Medicine|September 24, 2025
Optimizing KRAS Therapeutics for Non-Small Cell Lung CancerJeong Uk Lim, Marcelo V Negrao, David S HongClinical Lung Cancer|April 14, 2021
Management of Oligometastasis and Oligoprogression in Patients with Epidermal Growth Factor Receptor Mutation-Positive NSCLC in the Era of Third-Generation Tyrosine Kinase InhibitorsJeong Uk LimEwha Medical Journal|July 24, 2025
Impact of pulmonary tuberculosis on lung cancer screening: a narrative reviewJeong Uk LimTuberculosis and Respiratory Diseases|January 3, 2023
Update on Adjuvant Treatment in Resectable Non-Small Cell Lung Cancer and Potential Biomarkers Predicting Postoperative RelapseJeong Uk LimJournal of Thoracic Disease|June 13, 2022
Immune checkpoint inhibitor-related interstitial lung disease in patients with advanced non-small cell lung cancer: systematic review of characteristics, incidence, risk factors, and managementSeohyun Kim, Jeong Uk LimThoracic Cancer|December 13, 2021
Update on adjuvant therapy in completely resected NSCLC patientsJeong Uk Lim, Chang Dong YeoAnnals of Translational Medicine|July 16, 2021
A narrative review of current and potential prognostic biomarkers for immunotherapy in small-cell lung cancerJeong Uk Lim, Hye Seon KangJournal of Thoracic Disease|March 14, 2022
Narrative review: association between lung cancer development and ambient particulate matter in never-smokersJeong Uk Lim, Hyoung Kyu YoonSeminars in Oncology|March 10, 2022
Immune checkpoint inhibitors in patients with chronic kidney disease: Assessing their ability to cause acute kidney injury and informing their proper useJi Won Min, Jeong Uk LimCytokine|December 2, 2020
Potential predictive value of change in inflammatory cytokines levels subsequent to initiation of immune checkpoint inhibitor in patients with advanced non-small cell lung cancerJeong Uk Lim, Hyoung Kyu YoonPageof 55